Melanoma Treatment in Turkey: Complete Guide for US, UK, Canadian & Australian Patients

Understanding the UK Melanoma environment: Why Patients Look Abroad

This guide is for informational purposes only and does not replace professional medical recommendation. Always consult your doctor or specialist before making any treatment decisions.

• ›All prices are average prices and may vary depending on individual condition.

Melanoma treatment in Istanbul costs $8,000–$35,000 for a complete treatment course — compared to £30,000–£80,000 in the UK or $50,000–$200,000 in the USA, saving 60–75%. Globally, 320,000 new cases annually (IARC 2020). Turkey hosts 30+ JCI-accredited hospitals and treated over 50,000 international cancer patients in 2024. Istanbul's oncology centers follow ESMO. NCCN guidelines, offering Surgical excision, immune therapy (pembrolizumab/nivolumab), targeted therapy (BRAF/MEK inhibitors), radiation therapy at top-quality standards with tumor board review within 48–72 hours.

Private treatment in the US, UK, Canada, and Australia offers faster access but at a significant cost. Wide local excision (WLE) alone typically ranges from £5,000-£8,000. Sentinel lymph node biopsy adds £3,000-£5,000. For modern melanoma requiring immune therapy, private costs can exceed £ £100,000 annually for drugs like pembrolizumab or nivolumab, which NICE (UK), NCCN (US) has approved. NHS access may involve delays or eligibility criteria. This combination of healthcare wait times in the UK, Canada, and Australia anxiety. prohibitive private costs has led an increasing number of UK melanoma patients to explore treatment at JCI-accredited oncology centres in Istanbul.

Melanoma Treatment Options Available in Istanbul

Istanbul's leading oncology hospitals offer the full spectrum of melanoma care, from diagnosis and staging through to modern systemic therapies. Treatment is delivered by specialist tumour boards typically comprising a dermatopathologist, surgical cancer doctor, medical cancer doctor. radiation cancer doctor — the same team structure recommended by NICE (UK), NCCN (US). pan-Canadian oncology guidelines and ESMO clinical practice standards.

Surgical Management: Wide Local Excision & Sentinel Node biopsy

For early-stage melanoma, surgical excision remains the best standard. Istanbul's surgical oncologists perform wide local excision (WLE) with margins guided by Breslow thickness — 1 cm for thin melanomas (≤2 mm). 2 cm for thicker lesions (>2 mm) — consistent with NICE and ESMO guidelines. Sentinel lymph node biopsy (SLNB) is routinely performed for melanomas with Breslow thickness >1 mm or those with high-risk features such as ulceration. The procedure uses dual mapping with lymphoscintigraphy and blue dye, achieving sentinel node finding rates exceeding 95%.

immune therapy: Checkpoint Inhibitors (Same Drugs as NHS)

Istanbul's oncology centres provide the same first-line immune therapy agents used in the UK: immune therapy (checkpoint inhibitor). nivolumab (Opdivo) as monotherapy, or the combination of nivolumab with ipilimumab (Yervoy) for modern melanoma. These PD-1 and CTLA-4 checkpoint inhibitors have revolutionised melanoma treatment, achieving durable responses in 40-60% of patients with modern disease. Turkish oncologists follow the same dosing schedules and response monitoring protocols (RECIST 1.1 criteria) as their UK counterparts. For patients with BRAF V600-mutant melanoma — approximately 40-50% of cutaneous melanomas — targeted therapy with dabrafenib + trametinib or encorafenib + binimetinib is also available.

Isolated Limb Perfusion & advanced Surgical Techniques

For patients with in-transit metastases or locally modern melanoma confined to a limb, Istanbul's tertiary centres offer isolated limb perfusion (ILP) — a specialised technique that delivers high-dose cancer treatment directly to the affected limb while minimising systemic side effects. This procedure is available at only a handful of UK centres. typically involves lengthy waiting lists in the UK (NHS), Canada (provincial health), and Australia (Medicare public). In Istanbul, ILP is performed by experienced surgical oncology teams with comparable outcomes.

Transparent Cost Comparison: Istanbul vs UK

One of the most significant advantages of seeking melanoma treatment in Istanbul is cost transparency. Unlike private healthcare in the US, UK, Canada. Australia healthcare, where treatment costs often escalate with unexpected fees, Istanbul's complete treatment packages provide upfront pricing that includes all elements of care.

Cost Comparison Table (GBP | USD | CAD | AUD)

Initial consultation & pathology review: Istanbul £200-£400 / UK Private £300-£600. Wide local excision (Stage I-II): Istanbul £1,500-£2,500 / UK Private £5,000-£8,000. Sentinel lymph node biopsy: Istanbul £2,500-£3,500 / UK Private £3,000-£5,000. immune therapy (pembrolizumab, 12 months): Istanbul £8,000-£18,000 / UK Private £80,000-£120,000. Targeted therapy (BRAF/MEK, 12 months): Istanbul £7,000-£15,000 / UK Private £60,000-£100,000. PET-CT scan (staging): Istanbul £400-£700 / UK Private £1,500-£2,500. complete package (Stage II-III): Istanbul £6,000-£15,000 / UK Private £20,000-£50,000+

What's Included in a Typical Package

Istanbul's complete melanoma treatment packages typically include: airport transfers (return), VIP hospital accommodation or partnered 4-5 star hotel, English-speaking patient coordinator (24/7), all consultation fees with surgical. medical oncologists, investigation investigations (blood work, imaging, biopsy), surgical procedure with anaesthesia, all prescribed medications including immune therapy drugs, pathology. histology reports in English, discharge summary for UK GP/cancer doctor, and follow-up teleconsultations for 6-12 months. Most packages also offer a companion package covering accommodation and transfers for a friend or family member.

NHS vs Istanbul: Speed of Access Comparison

Time is of the essence in melanoma care. The NHS 62-day referral-to-treatment target is a minimum standard, but national data shows significant variation. In some NHS trusts, melanoma patients wait 8-14 weeks for wide local excision. up to 6 months for immune therapy initiation. In Istanbul, the pathway is dramatically faster: remote case review and tumour board discussion within 48-72 hours, travel preparation. visa (not required for UK citizens) within 1-2 weeks, initial consultation. staging (day 1-2 of arrival), surgery (day 3-5), and immune therapy initiation (day 7-10 post-op or immediately for modern disease). Total time from initial contact to first treatment can be as little as 2-3 weeks.

Continuity of Care: Returning to the UK After Treatment

A common concern among patients from the US, UK, Canada. Australia is how follow-up care will be managed after returning from Istanbul. The implementation is well-established. Before departure, the Istanbul hospital provides a complete medical report in English, including histopathology results, operative notes, treatment summary. recommended follow-up schedule. Imaging (CT, PET-CT, MRI) can be performed at the patient's local NHS hospital, with results shared electronically with both the Istanbul. UK teams. Istanbul oncologists remain available for teleconsultations throughout the follow-up period. For patients on ongoing immune therapy, treatment cycles can be coordinated. that initial cycles are administered in Istanbul, with a treatment plan that can be shared with a private healthcare in the US, UK, Canada. Australia cancer doctor for continuation. It is strongly recommended that patients inform their home-country doctor. specialist of their treatment plan before travelling to ensure smooth integration of care.

How to Choose a hospital in Istanbul for Melanoma Treatment

Istanbul has over 15 JCI-accredited hospitals with dedicated oncology centres. When evaluating options, patients from the US, UK, Canada. Australia should consider: JCI accreditation (non-negotiable for quality assurance), ESMO membership of the oncology team, availability of specific immune therapy drugs (pembrolizumab, nivolumab, ipilimumab), on-site pathology. BRAF investigation capability, specialist tumour board protocols, English-speaking consultant oncologists, dedicated international patient department, published outcomes data. transparent all-inclusive pricing. Our partner hospitals include Acıbadem Healthcare Group, Memorial Health Group, Anadolu Medical Center (Johns Hopkins affiliate), Medipol University hospital. Koç University hospital — all holding JCI accreditation and employing consultants with international training.

Practical Logistics for UK Patients

Flights from major hubs to Istanbul: London (3.5-4 hrs, several daily), New York (10 hrs), Toronto (10 hrs), Sydney (17 hrs with connection). US, UK, and Canadian citizens do not require a visa for stays of up to 90 days. Australian citizens can obtain a 90-day e-visa on arrival for stays under 90 days. Travel insurance should be arranged to cover the travel period, though treatment costs are covered by the hospital package. Most patients bring one companion. accommodation is included in complete packages, typically at 4-5 star hotels within 5-10 minutes of the hospital. Mobile roaming and SIM cards are readily available, and most hospitals offer complimentary WiFi. The time zone (GMT+3) is GMT+3 (8 hours ahead of US EST, 2 hours ahead of UK,. 7 hours ahead of Canada EST, 7 hours behind Australia EST), which is easily manageable

Why Book Through an Intermediary Platform?

We are an independent intermediary platform that works with a selection of JCI-accredited hospitals and leading surgeons in Turkey. Through our direct collaboration with hospitals, we can offer prices often 15-25% below direct clinic prices.

• We negotiate special conditions with our partner clinics — you get better prices than booking directly
• No hidden costs: we prepare a full cost estimate before your trip
• Personal support from English-speaking coordinators before, during and after the procedure
• We are also available after your hospital accommodation — follow-up, examinations and recommendation

Our Post-hospital Care

Our support does not end when you leave the hospital. We accompany you through the entire healing implementation:

• Virtual follow-up consultations with your oncology team
• 24/7 access to medical support via WhatsApp or phone
• Coordination of blood work and lab results with your home oncologist
• Personalized medication management plan and guidance
• Detailed discharge summary shared with your primary care team

Success Rates & Clinical Outcomes: Istanbul vs international Benchmarks

Istanbul's JCI-accredited oncology centres publish outcomes that align with international benchmarks. For Stage I-II melanoma treated with wide local excision alone, 5-year survival exceeds 90-95%, consistent with US (SEER), UK (NCRI), Canadian. Australian registry data. For Stage III melanoma treated with follow-up immune therapy (pembrolizumab or nivolumab), recurrence-free survival at 3 years reaches 55-65%, comparable to published results from the KEYNOTE-716. CheckMate 238 trials. For Stage IV (advanced) melanoma, the combination of nivolumab. ipilimumab achieves objective response rates of 50-60%, aligning with CheckMate 067 study outcomes. These results reflect adherence to ESMO and NCCN clinical practice guidelines and the availability of all modern treatment agents.